Keybanc Initiates Coverage On Walmart with Overweight Rating, Announces Price Target of $155
Keybanc analyst Bradley Thomas initiates coverage on Walmart (NYSE:WMT) with a Overweight rating and announces Price Target of $155.
Verve’s Stock Price Could Continue To Rise Through Clinical Progress – Despite Worries About “DeeperPocketed” Competition
Credit Suisse has initiated coverage on Verve Therapeutics Inc (NASDAQ:VERV) with a Neutral rating and a $48 target price. Its lead assets…
Analyst Initiates Coverage On This Genetic Testing Stock With Ongoing Transformation
Stephens initiated coverage on Myriad Genetics Inc (NASDAQ:MYGN) with an Equal-Weight rating and a price target of $22. The analyst writes that…
Stephen Initiates This Spatial Biology Player Citing Strong Competitive Position
Stephens started coverage on Akoya Biosciences Inc (NASDAQ:AKYA) with an Overweight rating and price target of $16. The analyst views Akoya…
Exane BNP Paribas Initiates Coverage On DraftKings with Underperform Rating
Exane BNP Paribas analyst Alistair Johnson initiates coverage on DraftKings (NASDAQ:DKNG) with a Underperform rating.
Credit Suisse Initiates Coverage On Bread Financial Holdings with Neutral Rating, Announces Price Target of $38
Credit Suisse analyst Moshe Orenbuch initiates coverage on Bread Financial Holdings (NYSE:BFH) with a Neutral rating and announces Price Target of $38.
Deutsche Bank Initiates Coverage On Ballys with Hold Rating, Announces Price Target of $23
Deutsche Bank analyst Carlo Santarelli initiates coverage on Ballys (NYSE:BALY) with a Hold rating and announces Price Target of $23.
Stephens & Co. Initiates Coverage On Guardant Health with Overweight Rating, Announces Price Target of $99
Stephens & Co. analyst Mason Carrico initiates coverage on Guardant Health (NASDAQ:GH) with a Overweight rating and announces Price Target of $99.
HC Wainwright Initiates This Eye-Focused Stock With Almost 400% Upside
HC Wainwright Matthew Caufield initiated coverage on Eyenovia Inc (NASDAQ:EYEN), focused on developing ophthalmic therapeutics based on the company’s microdose array…